| |
|
|
|
Proteostasis Therapeutics Inc.  
|
|
1.37 -0.01 (-0.01%) |
07-02 16:00 |
|
Open: |
1.38 |
Pre close: |
1.38 |
Target:
|
1.67 
|
|
High: |
1.42 |
Low: |
1.33 |
Resistance:
|
1.43
1.59
|
|
Volume: |
847,906 |
Market Cap: |
71M |
Support:
|
1.17
0.97
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.38
|
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
1.46 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
1.46 |
Stochastic Oscillator |
%K(14,3):
|
21.33  |
|
MA(250): |
1.40 |
%D(3): |
19.81 |
|
Average Volume(K) |
3-Month: |
104644
|
52-Week |
High:
|
4.72 |
|
10-Days: |
90688 |
Low: |
0.61 |
|
RSI |
RSI(14):
|
41.29 |
Change(%): |
34.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.061 |
Return on Equity (ttm) |
-70.8 |
Shares Out. (M) |
52.15 |
|
EPS Est. Current Year |
-2.750 |
Return on Assets (ttm) |
-35.7 |
Shares Float (M) |
44.14 |
|
EPS Est. Next Year |
-2.450 |
PEG Ratio |
0.00 |
% Held by Insiders |
17.86 |
|
EPS Est. Next Quarter |
-0.750 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
22.55 |
|
Forward EPS |
-1.160 |
Gross Profit (p.s.) |
0.096 |
Shares Short (K) |
3040 |
|
Book Value (p.s.) |
1.020 |
EBITDA (p.s.) |
-1.050 |
P/E |
-1.29 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.34 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-53.34 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-32.44 |
P/CF |
-1.34 |
|
|
|
|
|
|
